Abstract:It is notorious that cancer cells alter their metabolism to adjust to harsh environments of hypoxia and nutritional starvation. Metabolic reprogramming most often occurs in the tumor microenvironment (TME). TME is defined as the cellular environment in which the tumor resides. This includes surrounding blood vessels, fibroblasts, immune cells, signaling molecules and the extracellular matrix (ECM). It is increasingly recognized that cancer cells, fibroblasts and immune cells within TME can regulate tumor progression through metabolic reprogramming. As the most significant proportion of cells among all the stromal cells that constitute TME, cancer-associated fibroblasts (CAFs) are closely associated with tumorigenesis and progression. Multitudinous studies have shown that CAFs participate in and promote tumor metabolic reprogramming and exert regulatory effects via the dysregulation of metabolic pathways. Previous studies have demonstrated that curbing the substance exchange between CAFs and tumor cells can dramatically restrain tumor growth. Emerging studies suggest that CAFs within the TME have emerged as important determinants of metabolic reprogramming. Metabolic reprogramming also occurs in the metabolic pattern of immune cells. In the meanwhile, immune cell phenotype and functions are metabolically regulated. Notably, immune cell functions influenced by metabolic programs may ultimately lead to alterations in tumor immunity. Despite the fact that multiple previous researches have been devoted to studying the interplays between different cells in the tumor microenvironment, the complicated relationship between CAFs and immune cells and implications of metabolic reprogramming remains unknown and requires further investigation. In this review, we discuss our current comprehension of metabolic reprogramming of CAFs and immune cells (mainly glucose, amino acid, and lipid metabolism) and crosstalk between them that induces immune responses, and we also highlight their contributions to tumorigenesis and progression. Furthermore, we underscore potential therapeutic opportunities arising from metabolism dysregulation and metabolic crosstalk, focusing on strategies targeting CAFs and immune cell metabolic crosstalk in cancer immunotherapy.

Cross-Talk Between the Tumor Microenvironment, Extracellular Matrix, and Cell Metabolism in Cancer

Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment

Crosstalk between Hypoxia and Extracellular Matrix in the Tumor Microenvironment in Breast Cancer

The metabolic crosstalk of cancer-associated fibroblasts and tumor cells: Recent advances and future perspectives

Extracellular Matrix Signals as Drivers of Mitochondrial Bioenergetics and Metabolic Plasticity of Cancer Cells During Metastasis

Inflammation, Extracellular Matrix Remodeling, and Proteostasis in Tumor Microenvironment

Targeting Extracellular Matrix Interaction in Gastrointestinal Cancer: Immune Modulation, Metabolic Reprogramming, and Therapeutic Strategies

Extracellular Matrix in the Tumor Microenvironment and Its Impact on Cancer Therapy

Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments

Metabolic Interplay in the Tumor Microenvironment: Implications for Immune Function and Anticancer Response

The Crosstalk Between Cell Adhesion and Cancer Metabolism

Interactions and Implications in Tumor Progression

The Matrix Reloaded—The Role of the Extracellular Matrix in Cancer

The axis of tumor-associated macrophages, extracellular matrix proteins, and cancer-associated fibroblasts in oncogenesis

Cancer-Associated Fibroblasts: Master Tumor Microenvironment Modifiers

Metabolic crosstalk in the breast cancer microenvironment

Crosstalk between T lymphocyte and extracellular matrix in tumor microenvironment

The Epithelial–Mesenchymal Transition at the Crossroads between Metabolism and Tumor Progression

Metabolite activation of tumorigenic signaling pathways in the tumor microenvironment

Tumor microenvironment complexity and therapeutic implications at a glance

Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution